{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T16:03:06Z","timestamp":1788624186453,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011075","name":"David Geffen School of Medicine, University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["\/ NIDCR R01 DE019465"],"award-info":[{"award-number":["\/ NIDCR R01 DE019465"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["F30 DE028171"],"award-info":[{"award-number":["F30 DE028171"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["T90\/R90 DE007296"],"award-info":[{"award-number":["T90\/R90 DE007296"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.bone.2021.115945","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T02:06:18Z","timestamp":1617761178000},"page":"115945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Local RANKL delivery improves socket healing in bisphosphonate treated rats"],"prefix":"10.1016","volume":"148","author":[{"given":"Akrivoula","family":"Soundia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Hadaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Gkouveris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Bezouglaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Dry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Pirih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Aghaloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Tetradis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bone.2021.115945_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2021.115945_bb0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.coms.2015.06.002","article-title":"Medication-related osteonecrosis of the jaw: basic and translational science updates","volume":"27","author":"Allen","year":"2015","journal-title":"Oral Maxillofac Surg Clin North Am."},{"issue":"10","key":"10.1016\/j.bone.2021.115945_bb0015","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"1","key":"10.1016\/j.bone.2021.115945_bb0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1875-595X.2011.00004.x","article-title":"Reasons for extraction of permanent teeth in Greece: a five-year follow-up study","volume":"61","author":"Chrysanthakopoulos","year":"2011","journal-title":"Int. Dent. J."},{"issue":"4","key":"10.1016\/j.bone.2021.115945_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120756","article-title":"Impact of bisphosphonate-related osteonecrosis of the jaw on osteoporotic patients after dental extraction: a population-based cohort study","volume":"10","author":"Huang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2021.115945_bb0030","doi-asserted-by":"crossref","unstructured":"Stafford RS, Drieling RL, Hersh AL. National trends in osteoporosis visits and osteoporosis treatment, 1988\u20132003. Arch Intern Med. Jul 26 2004;164(14):1525\u201330.","DOI":"10.1001\/archinte.164.14.1525"},{"issue":"5","key":"10.1016\/j.bone.2021.115945_bb0035","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.eururo.2008.06.070","article-title":"Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate","volume":"54","author":"Walter","year":"2008","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bone.2021.115945_bb0040","doi-asserted-by":"crossref","unstructured":"Palmieri C, Fullarton JR, Brown J. Comparative efficacy of bisphosphonates in metastatic breast and prostate cancer and multiple myeloma: a mixed-treatment meta-analysis. Clin Cancer Res. Dec 15 2013;19(24):6863\u201372.","DOI":"10.1158\/1078-0432.CCR-13-2275"},{"issue":"5","key":"10.1016\/j.bone.2021.115945_bb0045","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1445-5994.2008.01824.x","article-title":"Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment","volume":"39","author":"Dickinson","year":"2009","journal-title":"Intern. Med. J."},{"issue":"12","key":"10.1016\/j.bone.2021.115945_bb0050","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/jbmr.2565","article-title":"Trends in media reports, oral bisphosphonate prescriptions, and hip fractures 1996-2012: an ecological analysis","volume":"30","author":"Jha","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.bone.2021.115945_bb0055","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/jbmr.2269","article-title":"The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine","volume":"29","author":"Wright","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.115945_bb0060","series-title":"Statement From American Society for Bone and Mineral Research, National Osteoporosis Foundation and National Bone Health Alliance. Nation's Scientific and Medical Bone Health Experts Call for Action On Dangers of Not Treating Osteoporosis More Aggressively","author":"Foundation NO","year":"2016"},{"key":"10.1016\/j.bone.2021.115945_bb0065","doi-asserted-by":"crossref","unstructured":"Khosla S, Cauley JA, Compston J, Kiel DP, Rosen C, Saag KG, et al. Addressing the crisis in the treatment of osteoporosis: a path forward. J Bone Miner Res. Dec 29 2016.","DOI":"10.1002\/jbmr.3074"},{"issue":"8","key":"10.1016\/j.bone.2021.115945_bb0070","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/jbmr.2888","article-title":"A crisis in the treatment of osteoporosis","volume":"31","author":"Khosla","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.115945_bb0075","doi-asserted-by":"crossref","unstructured":"Boyce BF, Xing L. Functions of RANKL\/RANK\/OPG in bone modeling and remodeling. Arch Biochem Biophys. May 15 2008;473(2):139\u201346.","DOI":"10.1016\/j.abb.2008.03.018"},{"issue":"5","key":"10.1016\/j.bone.2021.115945_bb0080","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.3892\/mmr.2015.3152","article-title":"Receptor activator of nuclear factor-kappaB ligand (RANKL)\/RANK\/osteoprotegerin system in bone and other tissues (review)","volume":"11","author":"Liu","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.bone.2021.115945_bb0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","article-title":"RANKL-RANK signaling in osteoclastogenesis and bone disease","volume":"12","author":"Wada","year":"2006","journal-title":"Trends Mol. Med."},{"issue":"10","key":"10.1016\/j.bone.2021.115945_bb0090","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1177\/0022034513500306","article-title":"Advances in the regulation of osteoclasts and osteoclast functions","volume":"92","author":"Boyce","year":"2013","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.bone.2021.115945_bb0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1749-6632.2012.06674.x","article-title":"The development of denosumab for the treatment of diseases of bone loss and cancer-induced bone destruction","volume":"1263","author":"Goessl","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.bone.2021.115945_bb0100","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1359\/jbmr.081112","article-title":"Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine\/human) RANKL","volume":"24","author":"Kostenuik","year":"2009","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.bone.2021.115945_bb0105","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/jbmr.2490","article-title":"OPG-fc but not zoledronic acid discontinuation reverses osteonecrosis of the jaws (ONJ) in mice","volume":"30","author":"de Molon","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.115945_bb0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bone.2016.06.011","article-title":"Osteonecrosis of the jaws (ONJ) in mice after extraction of teeth with periradicular disease","volume":"90","author":"Soundia","year":"2016","journal-title":"Bone."},{"key":"10.1016\/j.bone.2021.115945_bb0115","doi-asserted-by":"crossref","unstructured":"Hadaya D, Gkouveris I, Soundia A, Bezouglaia O, Boyce RW, Stolina M, et al. Clinically relevant doses of sclerostin antibody do not induce osteonecrosis of the jaw (ONJ) in rats with experimental periodontitis. J Bone Miner Res. Sep 5 2018.","DOI":"10.1002\/jbmr.3581"},{"issue":"8","key":"10.1016\/j.bone.2021.115945_bb0120","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/jbmr.379","article-title":"Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat","volume":"26","author":"Aghaloo","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.115945_bb0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2014.07.027","article-title":"Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: a novel ONJ mouse model","volume":"68","author":"de Molon","year":"2014","journal-title":"Bone."},{"issue":"7","key":"10.1016\/j.bone.2021.115945_bb0130","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/jbmr.1894","article-title":"Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice","volume":"28","author":"Kang","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.115945_bb0135","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bone.2019.03.031","article-title":"Vasculature submucosal changes at early stages of osteonecrosis of the jaw (ONJ)","volume":"123","author":"Gkouveris","year":"2019","journal-title":"Bone."},{"key":"10.1016\/j.bone.2021.115945_bb0140","unstructured":"Forstein DA, Bernardini C, Cole RE, Harris ST, Singer A. Before the breaking point: reducing the risk of osteoporotic fracture. J Am Osteopath Assoc. Feb 2013;113(2 Suppl 1):S5\u201324; quiz S5."},{"issue":"1","key":"10.1016\/j.bone.2021.115945_bb0145","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","article-title":"An overview and management of osteoporosis","volume":"4","author":"Sozen","year":"2017","journal-title":"Eur J Rheumatol."},{"issue":"4","key":"10.1016\/j.bone.2021.115945_bb0150","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.coms.2015.06.001","article-title":"Pathophysiology of osteonecrosis of the jaws","volume":"27","author":"Aghaloo","year":"2015","journal-title":"Oral Maxillofac Surg Clin North Am."},{"issue":"1","key":"10.1016\/j.bone.2021.115945_bb0155","first-page":"122","article-title":"Alveolar socket healing: what can we learn? Periodontol 2000","volume":"68","author":"Araujo","year":"2015","journal-title":"Jun"},{"issue":"10","key":"10.1016\/j.bone.2021.115945_bb0160","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1007\/s00198-018-4621-7","article-title":"Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study","volume":"29","author":"Shudo","year":"2018","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.bone.2021.115945_bb0165","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s10266-010-0153-0","article-title":"The effects of bisphosphonates on jaw bone remodeling, tissue properties, and extraction healing","volume":"99","author":"Allen","year":"2011","journal-title":"Odontology."},{"issue":"3","key":"10.1016\/j.bone.2021.115945_bb0170","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.joms.2006.10.076","article-title":"Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)]","volume":"65","author":"Harper","year":"2007","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"3","key":"10.1016\/j.bone.2021.115945_bb0175","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00198-013-2570-8","article-title":"Early effects of parathyroid hormone on bisphosphonate\/steroid-associated compromised osseous wound healing","volume":"25","author":"Kuroshima","year":"2014","journal-title":"Osteoporos. Int."},{"issue":"8","key":"10.1016\/j.bone.2021.115945_bb0180","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1007\/s00198-013-2277-x","article-title":"Weekly teriparatide injections successfully treated advanced bisphosphonate-related osteonecrosis of the jaws","volume":"24","author":"Yoshiga","year":"2013","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.115945_bb0185","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","article-title":"Parathyroid hormone: anabolic and catabolic actions on the skeleton","volume":"22","author":"Silva","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"issue":"2","key":"10.1016\/j.bone.2021.115945_bb0190","first-page":"383","article-title":"Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review","volume":"27","author":"Nicolatou-Galitis","year":"2019","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.bone.2021.115945_bb0195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjmed.2012.06.023","article-title":"Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday","volume":"126","author":"McClung","year":"2013","journal-title":"Am. J. Med."},{"issue":"11","key":"10.1016\/j.bone.2021.115945_bb0200","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00198-008-0604-4","article-title":"Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday","volume":"19","author":"Curtis","year":"2008","journal-title":"Osteoporos. Int."},{"issue":"3","key":"10.1016\/j.bone.2021.115945_bb0205","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1759720X13477714","article-title":"Bisphosphonate drug holiday: who, when and how long","volume":"5","author":"Diab","year":"2013","journal-title":"Ther Adv Musculoskelet Dis."},{"issue":"3","key":"10.1016\/j.bone.2021.115945_bb0210","article-title":"Molecular and cellular aspects of socket healing in the absence and presence of graft materials and autologous platelet concentrates: a focused review","volume":"10","author":"de Sousa","year":"2019","journal-title":"J Oral Maxillofac Res."},{"issue":"3\u20134","key":"10.1016\/j.bone.2021.115945_bb0215","first-page":"233","article-title":"The reasons for tooth extractions in adults and their validation","volume":"25","author":"Hull","year":"1997","journal-title":"J Dent. May-Jul"},{"issue":"1","key":"10.1016\/j.bone.2021.115945_bb0220","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/00220345910700010801","article-title":"Detection of periodontal disease activity with a scintillation camera","volume":"70","author":"Reddy","year":"1991","journal-title":"J. Dent. Res."},{"issue":"7","key":"10.1016\/j.bone.2021.115945_bb0225","first-page":"845","article-title":"Bone scan in dental diseases","volume":"19","author":"Tow","year":"1978","journal-title":"J. Nucl. Med."},{"issue":"12","key":"10.1016\/j.bone.2021.115945_bb0230","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.joms.2014.07.004","article-title":"Bisphosphonate uptake in areas of tooth extraction or periapical disease","volume":"72","author":"Cheong","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"3","key":"10.1016\/j.bone.2021.115945_bb0235","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2147\/CIA.S2046","article-title":"Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women","volume":"3","author":"Lambrinoudaki","year":"2008","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.bone.2021.115945_bb0240","doi-asserted-by":"crossref","unstructured":"Kohno N, Aogi K, Minami H, Nakamura S, Asaga T, Iino Y, et al. Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial. J Clin Oncol. May 20 2005;23(15):3314\u201321.","DOI":"10.1200\/JCO.2005.05.116"},{"key":"10.1016\/j.bone.2021.115945_bb0245","doi-asserted-by":"crossref","unstructured":"Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, et al. Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst. Jun 2 2004;96(11):879\u201382.","DOI":"10.1093\/jnci\/djh141"},{"issue":"2","key":"10.1016\/j.bone.2021.115945_bb0250","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10585-013-9624-3","article-title":"RANK expression on breast cancer cells promotes skeletal metastasis","volume":"31","author":"Blake","year":"2014","journal-title":"Clin Exp Metastasis."},{"issue":"6","key":"10.1016\/j.bone.2021.115945_bb0255","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.bone.2010.03.001","article-title":"Inhibition of RANKL increases the anti-tumor effect of the EGFR inhibitor panitumumab in a murine model of bone metastasis","volume":"46","author":"Canon","year":"2010","journal-title":"Bone."},{"key":"10.1016\/j.bone.2021.115945_bb0260","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/bonekey.2014.14","article-title":"Targeting RANKL in metastasis","volume":"3","author":"Dougall","year":"2014","journal-title":"Bonekey Rep."},{"issue":"3","key":"10.1016\/j.bone.2021.115945_bb0265","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0022034509359125","article-title":"Factors affecting wound healing","volume":"89","author":"Guo","year":"2010","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.bone.2021.115945_bb0270","doi-asserted-by":"crossref","first-page":"747584","DOI":"10.1155\/2014\/747584","article-title":"The role of the extracellular matrix components in cutaneous wound healing","volume":"2014","author":"Olczyk","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"10","key":"10.1016\/j.bone.2021.115945_bb0275","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.ajpath.2018.06.019","article-title":"Removal of pre-existing periodontal inflammatory condition before tooth extraction ameliorates medication-related osteonecrosis of the jaw-like lesion in mice","volume":"188","author":"Kim","year":"2018","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.bone.2021.115945_bb0280","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/0022034517732770","article-title":"Zoledronate impairs socket healing after extraction of teeth with experimental periodontitis","volume":"97","author":"Soundia","year":"2018","journal-title":"J. Dent. Res."},{"issue":"5","key":"10.1016\/j.bone.2021.115945_bb0285","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"4","key":"10.1016\/j.bone.2021.115945_bb0290","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.joms.2013.09.008","article-title":"Stage 0 osteonecrosis of the jaw in a patient on denosumab","volume":"72","author":"Aghaloo","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"5","key":"10.1016\/j.bone.2021.115945_bb0295","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","article-title":"Osteonecrosis of the jaw in a patient on Denosumab","volume":"68","author":"Aghaloo","year":"2010","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2021.115945_bb0300","doi-asserted-by":"crossref","unstructured":"Baron R, Ferrari S, Russell RG. Denosumab and bisphosphonates: different mechanisms of action and effects. Bone. Apr 1 2011;48(4):677\u201392.","DOI":"10.1016\/j.bone.2010.11.020"},{"key":"10.1016\/j.bone.2021.115945_bb0305","doi-asserted-by":"crossref","unstructured":"Li J, Mooney DJ. Designing hydrogels for controlled drug delivery. Nat Rev Mater. Dec 2016;1(12).","DOI":"10.1038\/natrevmats.2016.71"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221001071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221001071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:14:37Z","timestamp":1778940877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221001071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":61,"alternative-id":["S8756328221001071"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.115945","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local RANKL delivery improves socket healing in bisphosphonate treated rats","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.115945","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115945"}}